MNPR vs DRUG

Comparison between Monopar Therapeutics Inc (MNPR, Company) and Bright Minds Biosciences Inc (DRUG, Company).

Both MNPR and DRUG are from the Healthcare sector.

5-Year PerformanceMNPR has outperformed DRUG, delivering a return of +32.0% compared to +28.2%

MNPR vs DRUG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MNPR(COMPANY)	DRUG(COMPANY)
Market Cap	$728M	$728M
Max Drawdown	98.93%	97.68%
Sharpe Ratio	1.38	1.76
5Y Beta	1.67	-0.81
Industry	Biotechnology	Biotechnology
P/E Ratio	-47.78	-30.85
PEG Ratio	N/A	-0.08
5Y EPS CAGR	-5.81%	8.42%
Debt to Equity	0.00%	0.03%
Free Cash Flow Yield	-1.38%	-2.00%
P/B Ratio	4.94	3.34

Market Cap

Winner

MNPR

$728M

DRUG

$728M

Max Drawdown

MNPR

98.93%

Winner

DRUG

97.68%

Sharpe Ratio

MNPR

1.38

Winner

DRUG

1.76

5Y Beta

MNPR

1.67

Winner

DRUG

-0.81

Industry

MNPR

Biotechnology

DRUG

Biotechnology

P/E Ratio

Winner

MNPR

-47.78

DRUG

-30.85

PEG Ratio

MNPR

N/A

DRUG

-0.08

5Y EPS CAGR

MNPR

-5.81%

Winner

DRUG

8.42%

Debt to Equity

Winner

MNPR

0.00%

DRUG

0.03%

Free Cash Flow Yield

Winner

MNPR

-1.38%

DRUG

-2.00%

P/B Ratio

MNPR

4.94

Winner

DRUG

3.34

MNPR vs DRUG - Historical Returns

Returns include dividend reinvestment.

Period	MNPR	DRUG
1 month	+56.96%	+23.00%
3 months	+93.60%	-17.82%
6 months	+50.60%	-10.11%
1 year	+128.09%	+185.42%
5 years(CAGR)	+31.98%	+28.20%
Max(CAGR)	-3.35%	+21.02%

Winner

MNPR

+56.96%

DRUG

+23.00%

Winner

MNPR

+93.60%

DRUG

-17.82%

Winner

MNPR

+50.60%

DRUG

-10.11%

MNPR

+128.09%

Winner

DRUG

+185.42%

5Y(CAGR)

Winner

MNPR

+31.98%

DRUG

+28.20%

Max(CAGR)

MNPR

-3.35%

Winner

DRUG

+21.02%

MNPR vs DRUG - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

Year	MNPR	DRUG
2026	+60.43%	-10.60%
2025	+193.88%	+89.83%
2024	+1089.19%	+1859.10%
2023	-85.34%	-63.33%
2022	-30.29%	-78.04%
2021	-49.53%	-41.30%
2020	-64.56%	N/A
2019	-37.36%	N/A

MNPR vs DRUG Drawdown Comparison

The maximum drawdown for MNPR was -98.93%, occurring on Nov 20, 2023. This drawdown has not yet recovered.

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The current MNPR drawdown is -21.56%. The current DRUG drawdown is -22.27%.

Rank	MNPR	DRUG
#1	-98.93% Dec 20, 2019 - Nov 20, 2023	-97.68% Nov 8, 2021 - Oct 18, 2024
#2	N/A	-58.28% Nov 6, 2024 - Sep 29, 2025
#3	N/A	-38.35% Jan 7, 2026 - Jun 15, 2026
#4	N/A	-27.84% Mar 22, 2021 - Aug 24, 2021
#5	N/A	-26.13% Oct 21, 2025 - Nov 28, 2025
#6	N/A	-19.30% Dec 16, 2025 - Jan 7, 2026
#7	N/A	-16.21% Sep 30, 2025 - Oct 9, 2025
#8	N/A	-14.42% Oct 11, 2021 - Nov 3, 2021
#9	N/A	-9.05% Oct 24, 2024 - Nov 4, 2024
#10	N/A	-7.65% Oct 14, 2025 - Oct 21, 2025
#11	N/A	-5.42% Dec 11, 2025 - Dec 16, 2025
#12	N/A	-4.62% Sep 24, 2021 - Sep 29, 2021
#13	N/A	-4.59% Dec 8, 2025 - Dec 10, 2025
#14	N/A	-4.38% Aug 24, 2021 - Sep 1, 2021
#15	N/A	-3.81% Sep 1, 2021 - Sep 17, 2021